We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Olympus Highlights Surgical Visualization Platform for Future-Proof Endoscopic Surgery

By HospiMedica International staff writers
Posted on 31 Jan 2024

Olympus Corporation (Tokyo, Japan) is showing the latest innovations that redefine possibilities in healthcare, from state-of-the-art imaging technology to breakthrough medical procedures, at Arab Health 2024.

At the 49th edition of Arab Health, Olympus is showcasing, amongst others, its latest product launch, the VISERA ELITE III surgical visualization platform - an innovative and open solution that brings together multiple observation modes for future-proof endoscopic surgery. VISERA ELITE III offers various imaging functions, all supported in one system enabling minimally invasive therapies such as laparoscopic colectomy and laparoscopic cholecystectomy. By providing surgeons with multiple observation modes, the all-in-one system supports standardization and increases efficiency in the operating room. Users can also set up customized departmental profiles on VISERA ELITE III for different medical disciplines such as general surgery, urology, gynecology, ENT surgery, and more.


Image: The VISERA ELITE III surgical visualization platform (Photo courtesy of Olympus)
Image: The VISERA ELITE III surgical visualization platform (Photo courtesy of Olympus)

Olympus is also highlighting the POWERSEAL Sealer/Divider which supports the treatment of colon, stomach, lung, and other major types of cancer – but also non-cancer conditions – and can therefore be applied in various medical specialties, from lower to upper gastrointestinal surgery and gynecology, as well as in urology and other areas. Also being highlighted is the iTind, a non-surgical device for the minimally invasive treatment of Benign Prostatic Hyperplasia (BPH). The temporarily implanted nitinol device is inserted in an efficient and straightforward procedure with a short learning curve. Through gentle pressure on the tissue and localized ischemia, the iTind procedure aims to reshape the tissue of the prostatic urethra and the bladder neck. After 5-7 days, the iTind device is removed leaving nothing behind.

In addition, Olympus is showcasing the CELERIS disposable sinus debrider, a single-use microdebrider designed for ENTs who want the power and resection efficiency of a traditional sinus debrider in a convenient single-use solution, without compromising performance or quality. Within its medical portfolio, Olympus is showcasing its most advanced endoscopy system with AI, EVIS X1 which represents a range of new, easy-to-use technologies that aim to revolutionize the way gastrointestinal disorders can be detected, characterized, and treated.

Related Links:
Olympus Corporation


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Gold Member
X-Ray QA Meter
T3 AD Pro
New
Fetal and Maternal Monitor
F9 Series
New
LED Surgical Light
Convelar 1670 LED+/1675 LED+/1677 LED+

Latest ARAB HEALTH 2024 News

Famed Premieres New Revolutionary Control System for Surgical Operating Tables

Dräger Presents Specialist Solutions for Acute Care

ATOM Medical Highlights Advanced Infant Incubators